0000000000414697

AUTHOR

Ivan Cvjetko

showing 3 related works from this author

Position Paper on Young Vascular Surgeons Training of the Mediterranean Federation for the Advancing of Vascular Surgery (MeFAVS): State of the Art a…

2021

ABSTRACT The Mediterranean Federation for the Advancing of Vascular Surgery (MeFAVS) was founded in 2018, with the aim to promote cooperation among vascular professionals within Mediterranean countries. Due to its prominent social and economic impact on national health systems, diabetic peripheral artery was selected as the very first topic to be investigated by the federation. In this second paper, different experiences from delegates of participating countries were shared to define common strategies to harmonize, standardize, and optimize education and training in the Vascular Surgery specialty.

medicine.medical_specialtyArterial diseasemedia_common.quotation_subjectVascular SurgerySettore MED/22 - Chirurgia VascolareTraining (civil)Peripheral Arterial DiseaseState (polity)medicineMediterranean SeaHumansTrainingEconomic impact analysisVascular surgery specialtymedia_commonNational healthSurgeonsbusiness.industryMediterranean RegionInternship and ResidencyGeneral MedicineVascular surgeryendovascular surgery; Mediterranean sea; training; vascular surgeryEducation Medical GraduateFamily medicineEndovascular SurgeryPosition paperSurgeryClinical CompetenceCurriculumCardiology and Cardiovascular MedicinebusinessVascular Surgical ProceduresDiabetic AngiopathiesLearning CurveProgram EvaluationSpecialization
researchProduct

Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy.

2021

Summary Background Among asymptomatic patients with severe carotid artery stenosis but no recent stroke or transient cerebral ischaemia, either carotid artery stenting (CAS) or carotid endarterectomy (CEA) can restore patency and reduce long-term stroke risks. However, from recent national registry data, each option causes about 1% procedural risk of disabling stroke or death. Comparison of their long-term protective effects requires large-scale randomised evidence. Methods ACST-2 is an international multicentre randomised trial of CAS versus CEA among asymptomatic patients with severe stenosis thought to require intervention, interpreted with all other relevant trials. Patients were eligib…

Malemedicine.medical_specialtyTime FactorsTime Factormedicine.medical_treatmentCarotid StenosiMEDLINECarotid endarterectomyRate ratioRisk AssessmentAsymptomaticlaw.inventionRandomized controlled triallawRisk Factorscarotid artery stenting (CAS); carotid endarterectomy (CEA)StentmedicineHumansCarotid StenosisStrokeEndarterectomyAgedEndarterectomy Carotidbusiness.industrycarotid arteryRisk FactorArticlesGeneral Medicinetrialmedicine.diseaseSettore MED/22 - CHIRURGIA VASCOLARESurgeryStrokeStenosisTreatment Outcomecarotid artery stenting (CAS)Settore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREFemaleStentsHuman medicinemedicine.symptomcarotid endarterectomy (CEA)businessHumanLancet (London, England)
researchProduct

European training requirements in vascular surgery

2022

ispartof: INTERNATIONAL ANGIOLOGY vol:41 issue:2 pages:91-104 ispartof: location:Italy status: published

EuropeEducation Medical GraduateHumansCurriculumCardiology and Cardiovascular MedicineVascular Surgical ProceduresInternational Angiology
researchProduct